LONDON — The rapid rise of GLP-1 weight-loss medications is reshaping not only the pharmaceutical market but also the global supply of whey protein, a key ingredient in everything from nutrition shakes and protein powders to snack bars, chips and other packaged foods.
Industry analysts say surging consumer demand for medications such as Mounjaro has helped push whey protein prices to record highs, raising concerns about supply availability and increasing costs for manufacturers and retailers alike.
Healthcare providers often advise patients taking GLP-1 medications to increase their protein intake to help preserve muscle mass during weight loss. At the same time, protein has become one of the most sought-after attributes in food and beverage products, prompting manufacturers to add protein to an expanding range of everyday items.
Whey protein, derived from milk during the cheese-making process, has long been a staple in sports nutrition products. However, it has increasingly moved into mainstream retail, appearing in products ranging from popcorn and baked goods to convenience store snacks and meal replacements.
The result is a market struggling to keep pace with demand.
Food-grade whey powder prices in northwestern Europe have climbed to about €1,700 ($1,940) per metric ton, the highest level on record and more than 50% above the start of the year, according to DCA Market Intelligence. Data from the dairy commodity intelligence platform Vesper shows that the price of whey protein concentrate with 80% protein has risen from about £4,300 ($5,820) per ton in June 2023 to nearly £23,800 ($32,220) per ton this year.
“If you look at overall supply and demand, the market is still finding a home for the product, but there’s clearly a shortage in the sense that people want more than there physically is available,” Vesper analyst Jasper Endlich told The Guardian. “Manufacturers would like to produce more and build safety stocks, but they haven’t been able to do that.”
For retailers, the supply squeeze could have implications across several high-growth categories. Protein-enhanced foods and beverages have become increasingly important traffic drivers as consumers seek products that align with wellness and weight-management goals. Continued increases in whey costs could lead to higher shelf prices, reformulated products or tighter inventory levels.
A recent report from the U.S. Department of Agriculture's Dairy Market News highlighted tightening supplies of whey protein concentrate, particularly WPC 34%, a widely used dairy ingredient. Market participants reported rising prices across the board, with some suppliers already sold out through the rest of 2026.
Industry sources also expect further pressure after one manufacturer reportedly plans to stop producing WPC 34% later this year, which could further reduce available supply.
Smaller brands are already feeling the impact. Erika Tamayo, founder of protein brand Hermosa, said ingredient costs have climbed steadily over the past two years and have recently doubled compared with the previous quarter.
“We are now all fighting for stock allocation,” Tamayo told The Guardian. “Some of the bigger companies have absorbed all the price increases as they’re all trying to get market share and grow their businesses. Bigger players have more possibilities, so they don’t have to compromise.”
Tamayo noted that the growing consumer focus on protein has prompted manufacturers to add whey protein to a wide range of products, intensifying competition for supply.
“Once GLP-1s started soaring, people realized how important protein is in their diet,” she said. “Then loads of products in mainstream supermarkets started adding whey protein to everything. Everything now has protein in it because of the focus on diets.”
Industry observers say the market is responding. New production facilities are coming online, while some manufacturers are exploring protein blends that combine whey with milk proteins to reduce costs while maintaining nutritional value.
“We’re seeing new production plants open,” Endlich said. “There are ways for companies to manage the pressure while supply catches up.”
For mass retailers, grocers and convenience store operators, the whey protein shortage underscores the growing influence of GLP-1 medications on consumer purchasing habits. As weight-management drugs continue to gain adoption and protein remains a top consumer priority, retailers may need to navigate higher ingredient costs and evolving product assortments across some of their fastest-growing wellness categories.
Submit Your Press Release
Have news to share? Send us your press releases and announcements.
Send Press Release
